sorbitol has been researched along with framycetin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Conn, HO; Leevy, CM; Levy, LL; Maddrey, WC; Rodgers, JB; Seeff, L; Vlahcevic, ZR | 1 |
| Gustafsson, BE; Norin, KE | 1 |
| Atterbury, CE; Conn, HO; Maddrey, WC | 1 |
| Bircher, J; Guggenheim, P; Haemmerli, UP; Müller, J | 1 |
| Conn, HO | 2 |
| Conn, HO; Elkington, SG; Floch, MH | 1 |
| Dodd, AN; Gilliham, M; Tester, M; Tracy, FE; Webb, AA | 1 |
4 trial(s) available for sorbitol and framycetin
| Article | Year |
|---|---|
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
Topics: Aged; Ammonia; Blood; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Mental Processes; Middle Aged; Neomycin; Prospective Studies; Sorbitol; Trail Making Test | 1977 |
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
Topics: Clinical Trials as Topic; Disaccharides; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neomycin; Placebos; Sorbitol | 1978 |
[Dilemmas of clinical experimentation: use of lactulose in portocaval encephalopathy].
Topics: Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Placebos; Research Design; Sorbitol; Time Factors | 1974 |
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
Topics: Adult; Aged; Alcoholism; Ammonia; Brain Diseases; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Disaccharides; Electroencephalography; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Intestines; Liver Cirrhosis; Male; Mental Disorders; Middle Aged; Neomycin; Neurologic Manifestations; Sorbitol | 1969 |
6 other study(ies) available for sorbitol and framycetin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Development of germfree animal characteristics in conventional rats in antibiotics.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Bacitracin; Bile Pigments; Cholestanol; Clofibrate; Colistin; Erythromycin; Feces; Ferrous Compounds; Germ-Free Life; Intestines; Kanamycin; Male; Metronidazole; Neomycin; Oxytetracycline; Penicillin G; Rats; Sorbitol; Sulfathiazoles; Tetracycline | 1977 |
Treatment of chronic portal-systemic encephalopathy with lactulose.
Topics: Brain Diseases; Diet Therapy; Dietary Proteins; Disaccharides; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Sorbitol | 1966 |
Interactions of lactulose and neomycin.
Topics: Cathartics; Disaccharides; Drug Interactions; Feces; Humans; Hydrogen-Ion Concentration; Intestines; Liver Diseases; Neomycin; Sorbitol | 1972 |
NaCl-induced changes in cytosolic free Ca2+ in Arabidopsis thaliana are heterogeneous and modified by external ionic composition.
Topics: Arabidopsis; Calcium; Calcium Signaling; Cytosol; Membrane Potentials; Neomycin; Osmolar Concentration; Osmosis; Photons; Seedlings; Sodium Chloride; Solutions; Sorbitol | 2008 |